Roche In Search Of Partnerships, Innovation In China Rather Than Outsourcing; Biologics Will Drive Innovation
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - With the increasing rate of patent filings granted in China, Roche will pay more attention to in-licensing opportunities in China, a Roche senior executive told the China Biopharmaceutical Globalization and Intellectual Property Strategy conference in Shanghai, Nov. 20
You may also be interested in...
Despite A Wide Retreat From Discovery Research By Multinationals In Japan, Some Are Staying Put (Part 2 Of 3)
Countering the rush out of Japan's discovery research sector, a few global pharmaceutical corporations are maintaining early research operations or even expanding their presence in this area.
Despite A Wide Retreat From Discovery Research By Multinationals In Japan, Some Are Staying Put (Part 2 Of 3)
Countering the rush out of Japan's discovery research sector, a few global pharmaceutical corporations are maintaining early research operations or even expanding their presence in this area.
Roche Global Licensing Director Stella Xu and Business Development Director Frank Grams On Seeking More Innovation In China And Korea: An Interview With PharmAsia News (Part 2 of 2)
Roche recently expanded its investment in innovation in Asia by opening its fourth Global Partnering office in Shanghai. Roche Global Licensing Director Stella Xu and Business Development Director Frank Grams sat down with PharmAsia News' Shanghai Bureau to talk about the mission of the newly established partnering site and Roche's partnering strategies in Asia.